Literature DB >> 7967427

Influence of fractionated total body irradiation on mucosal toxicity in intensified conditioning regimens for autologous bone marrow transplantation in pediatric cancer patients.

A Borgmann1, W Emminger, W Emminger-Schmidmeier, C Peters, I Gatterer-Menz, G Henze, H Gadner.   

Abstract

From April 1988 to March 1991 28 children with generalized solid tumors (N = 15) or hematologic malignancies (N = 13) received intensified myelotoxic regimens followed by autologous stem cell rescue (ABMT). These intensified regimens consisted of 12 Gy fractionated total body irradiation (FTBI) and 2 (or 3) cytotoxic drugs (group A, n = 19) or a combination of 3 cytotoxic drugs (group B, n = 9). FTBI-containing regimens produced more severe mucositis > = WHO grade 3 (p = 0.01) and a longer duration of severe mucositis. The mucositis had a median duration of 8 days (range 0-28) in group A compared with median 0 days (range 0-7) in group B (p < 0.01). Acute renal and liver toxicity were not different. The probability of overall survival at day +100 was 89% in all patients. In terms of long-term survival FTBI containing regimen did not prove superior: 5 out of 19 patients in group A and 6 out of 9 patients in group B have been survivors for a minimum of 3 years. In conclusion, severe gastrointestinal toxicity of such intensive regimens is avoidable if FTBI is omitted.

Entities:  

Mesh:

Year:  1994        PMID: 7967427     DOI: 10.1055/s-2008-1046618

Source DB:  PubMed          Journal:  Klin Padiatr        ISSN: 0300-8630            Impact factor:   1.349


  2 in total

1.  Loss of immune homeostasis dictates SHIV rebound after stem-cell transplantation.

Authors:  Christopher W Peterson; Clarisse Benne; Patricia Polacino; Jasbir Kaur; Cristina E McAllister; Abdelali Filali-Mouhim; Willi Obenza; Tiffany A Pecor; Meei-Li Huang; Audrey Baldessari; Robert D Murnane; Ann E Woolfrey; Keith R Jerome; Shiu-Lok Hu; Nichole R Klatt; Stephen DeRosa; Rafick P Sékaly; Hans-Peter Kiem
Journal:  JCI Insight       Date:  2017-02-23

2.  Oral mucositis in patients with acute myeloid leukemia treated with allogeneic hematopoietic stem cell transplantation in relation to the conditioning used prior to transplantation.

Authors:  Aleksandra Wysocka-Słowik; Lidia Gil; Zuzanna Ślebioda; Agnieszka Kręgielczak; Barbara Dorocka-Bobkowska
Journal:  Ann Hematol       Date:  2021-06-12       Impact factor: 3.673

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.